does semaglutide cause breast cancer The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and | Cancer and Metastasis Reviews Dr. Tara Narula | New

We have supplements and IVs meant to increase muscle mass

Legacy effect of intensive glucose control on major adverse cardiovascular outcome: systematic review and meta-analyses of trials according to different scenarios

muciniphila and the symbiotic microbiota Given the inherent limitations of single-strain probioticssuch as their ecological niche specificity, limited functional diversity, and the complex dynamics of the gut ecosystemresearchers have increasingly turned to the development of multi-strain consortia with complementary functionalities, which offer a more effective strategy for regulating the intestinal microecology [113, 114]

PMID: 39815782

As use of these drugs continues to expand, it becomes increasingly important to understand their real-world benefits and risks across populations. Guo conducted this research in collaboration with William Donahoo, M.D., clinical professor and chief of the UF Health Division of Endocrinology, Diabetes and Metabolism, and Steven T DeKosky, M.D., deputy director of the McKnight Brain Institute and professor of Alzheimer's research, neurology and neuroscience in the UF Department of Neurology

At 48 weeks, a majority of participants on higher doses lost 15% of their body weight